Arkolith/Insider Trading/CDAK/Form 4

ARCH Venture Fund VIII Overage, L.P.

10% OwnerCodiak BioSciences, Inc. (CDAK) · full profile →Form 4 · filed Sep 15, 2022
Net Buying
Open-Market Buys
$7.5M
Open-Market Sells
$0
Net Open-Market Flow
$7.5M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 13, 2022Buy(P)5.0M$1.50$7.5M8.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 13, 2022Buy(P)5.0M——5.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-22-019586) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML